Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Lisak

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Annals of Clinical and Laboratory Science|July 1, 1975
Immunologic aspects of myasthenia gravisR P Lisak
Neurology|July 1, 1988
Overview of the rationale for immunomodulating therapies in multiple sclerosisR P Lisak
Annals of Neurology|June 1, 1986
Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?B Zweiman, R P Lisak
Chest Surgery Clinics of North America|June 21, 2001
The thymus and myasthenia gravisS Ragheb, R P Lisak
Research Communications in Chemical Pathology and Pharmacology|July 1, 1973
Comparative proliferative responses of peripheral blood and peritoneal exudate cells to homologous myelin basic proteinR P Lisak, B Zweiman
Neurology|April 1, 1993
Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter diseaseN Nadkarni, R P Lisak
Clinical Neuropharmacology|April 1, 1993
Immunopharmacologic therapy in myasthenia gravisA Shah, R P Lisak
Annals of the New York Academy of Sciences|July 21, 1998
Immune regulation and myasthenia gravisS Ragheb, R P Lisak
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1975
Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositisR P Lisak, B Zweiman
Annals of Neurology|October 1, 1993
Multiple sclerosis: genetic background versus environmentS Ragheb, R P Lisak
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Annals of Clinical and Laboratory Science|July 1, 1975
Immunologic aspects of myasthenia gravisR P Lisak
Neurology|July 1, 1988
Overview of the rationale for immunomodulating therapies in multiple sclerosisR P Lisak
Annals of Neurology|June 1, 1986
Lymphocyte phenotypes in the multiple sclerosis lesion--what do they mean?B Zweiman, R P Lisak
Chest Surgery Clinics of North America|June 21, 2001
The thymus and myasthenia gravisS Ragheb, R P Lisak
Research Communications in Chemical Pathology and Pharmacology|July 1, 1973
Comparative proliferative responses of peripheral blood and peritoneal exudate cells to homologous myelin basic proteinR P Lisak, B Zweiman
Neurology|April 1, 1993
Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter diseaseN Nadkarni, R P Lisak
Clinical Neuropharmacology|April 1, 1993
Immunopharmacologic therapy in myasthenia gravisA Shah, R P Lisak
Annals of the New York Academy of Sciences|July 21, 1998
Immune regulation and myasthenia gravisS Ragheb, R P Lisak
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1975
Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositisR P Lisak, B Zweiman
Annals of Neurology|October 1, 1993
Multiple sclerosis: genetic background versus environmentS Ragheb, R P Lisak
Pageof 23